Use of hybrid closed loop technology in pregnancy - benefits are system specific...

Watch the recording now!

This webinar will review recent diabetes technology advances which are transforming the management of diabetes before, during and after pregnancy. It will examine the benefits and barriers to using hybrid closed-loop (HCL) insulin delivery during type 1 diabetes pregnancy, and focus on which systems deliver clinical benefits for mothers and babies. Practical tips for starting and optimising HCL use throughout pregnancy, including during labour and birth, will be shared.

Educational outcomes:

  • Understand the impact of HCL use on maternal glucose outcomes
  • Understand which HCL systems offer clinically relevant time-in-range improvements
  • Increase confidence starting and optimising HCL use during pregnancy


  • Dr Helen Murphy, Professor of Medicine (Diabetes and Antenatal Care) at the University of East Anglia, and Clinical Lead for the National Pregnancy in Diabetes (NPID) Audit
  • Dr Tara Lee, Clinical Research Fellow at the University of East Anglia and the Norfolk & Norwich University Hospitals NHS Foundation Trust.

Play video